-

$undefined

N/A

(N/A)

BioInvent International AB :BINV

Location: | Industry: | Sector:


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Short % of Float

0.00%

Insider Ownership

0.00%

Institutional Own.

0.00%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Phase 2

Initiation

BI-1910 + KEYTRUDA Details
Solid tumor/s, Cancer

Phase 2a

Data readout

BI-1206 +/- rituximab & acalabrutinib Details
Cancer, Solid tumor/s, Non-Hodgkin lymphoma

Phase 2a

Data readout

BI-1808 +/- KEYTRUDA Details
Advanced malignancies, Cancer

Phase 2a

Data readout

BT-001 + KEYTRUDA Details
Cancer, Solid tumor/s

Phase 1/2

Update

BI-1607 Details
Solid tumor/s, Cancer

Phase 1

Data readout